Considering the critical role of the STAT3 signaling pathway in HDGF/TKT-driven breast cancer radioresistance, we assessed the effects of Stattic treatment combined with HDGF-depletion on breast cancer radioresistance using the MDA-MB-231 cells xenograft models. This evidence concerns the gene HDGF and breast carcinoma.